FDA Adverse Events Reporting System (FAERS)

/ Nov 16, 2017

FDA operates one of the largest and most complete databases of adverse events on drugs marketed in the US. FAERS data is now easily searchable online.

Read More
Real-Time Analytics

Is Real-Time Analytics Right for Your Organization?

/ Oct 31, 2017

Big Data has been around for years, but the concept of real-time analytics has remained a challenge. But with current technological innovations, including automation and AI, that's all changing.

Read More
Online Drug Safety

Safety of Drugs Bought Abroad or Online

/ Oct 26, 2017

Many US patients are obtaining drugs from online and foreign pharmacies. Bart Cobert examines this trend, and its impact on drug safety.

Read More

EU Update: EMA Relocation & EU Inspections

/ Sep 14, 2017

The EU is in turmoil as the Brexit EMA relocation continues to percolate, particularly behind closed doors. Also EU inspections are being discussed.

Read More

Laws, Regulations, Guidances, Guidelines and Best Practices

/ Aug 22, 2017

Bart Cobert attempts to clear up the confusion around Drug Safety and PV requirements in different regions of the world, with a focus on US and EU requirements.

Read More

Risk Management: Anticipate > Eliminate > Mitigate

/ Aug 10, 2017

Risk. From the time we wake up, we are faced with risks. Knowingly or not, our waking hours are spent trying to either eliminate or mitigate those risks.

Read More
Brexit, Again

Brexit, Again

/ Jul 21, 2017

The UK has given official notice that they will withdraw from the EU. With Brexit seemingly moving ahead, Bart Cobert looks at its effects on the world of pharmacovigilance.

Read More

When Medical Information Becomes a Drug Safety Issue

/ Jun 27, 2017

Closely-tied Medical Information and Drug Safety departments, with a seamless adverse event intake and hand-off processs, offer better quality control, scalability and risk mitigation.

Read More
AEs in Children

Drug Safety and AEs in Children

/ Jun 16, 2017

As the saying goes, children are not small adults. Thus the approach of pharmacovigilance to AEs in children needs to be different from that in adults.

Read More

Phase I Disasters … And Some Good News

/ Apr 27, 2017

Every couple of years, the pharmacology world reads about a phase I trial that has significant problems or is a frank disaster.

Read More